EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy

Heng Dong iD, Qiang Li iD, Yu Zhang iD, Meng Ding, Zhaogang Teng iD, Yongbin Mou iD

Advanced Science · 2023-06 · 10 (18)

DOI: 10.1002/advs.202301339 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 23.04.2023. Verfasst von Heng Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, 30 Zhongyang Road, Nanjing, Jiangsu, 210008, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 359 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Sciences Foundation of China, Jiangsu Provincial Key Research and Development Program, Nanjing Medical Science and Technique Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cell (DC)‐based cancer immunotherapy has exhibited remarkable clinical prospects because DCs play a central role in initiating and regulating adaptive immune responses. However, the application of traditional DC‐mediated immunotherapy is limited due to insufficient antigen delivery, inadequate antigen presentation, and high levels of immunosuppression. To address these challenges, engineered biomaterials have been exploited to enhance DC‐mediated immunotherapeutic effects. In this review, vital principal components that can enhance DC‐mediated immunotherapeutic effects are first introduced. The parameters considered in the rational design of biomaterials, including targeting modifications, size, shape, surface, and mechanical properties, which can affect biomaterial optimization of DC functions, are further summarized. Moreover, recent applications of various engineered biomaterials in the field of DC‐mediated immunotherapy are reviewed, including those serve as immune component delivery platforms, remodel the tumor microenvironment, and synergistically enhance the effects of other antitumor therapies. Overall, the present review comprehensively and systematically summarizes biomaterials related to the promotion of DC functions; and specifically focuses on the recent advances in biomaterial designs for DC activation to eradicate tumors. The challenges and opportunities of treatment strategies designed to amplify DCs via the application of biomaterials are discussed with the aim of inspiring the clinical translation of future DC‐mediated cancer immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsImmunosuppression TherapyAntigen PresentationBiocompatible MaterialsDendritic Cells

Stichwörter der Autor:innen

biomaterialscancer immunotherapydendritic cellsnanovaccinetumor microenvironment

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, 30 Zhongyang Road, Nanjing, Jiangsu, 210008, P. R. China.
  • Key Laboratory for Organic Electronics and Information Displays, Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing Univ…

ORCID-Profile: Heng Dong, Qiang Li, Yu Zhang, Zhaogang Teng, Yongbin Mou

Förderung

  • National Natural Sciences Foundation of China
  • Jiangsu Provincial Key Research and Development Program
  • Nanjing Medical Science and Technique Development Foundation
  • "3456" Cultivation Program for Junior Talents of Nanjing Stomatological Hospital, Medical School of Nanjing University
  • Project of State Key Laboratory of Organic Electronics and Information Displays, the Nanjing University of Posts & Telecommunications

Zitieren

APA

Dong, H., Li, Q., Zhang, Y., Ding, M., Teng, Z., & Mou, Y. (2023). Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy. Advanced Science, 10(18). https://doi.org/10.1002/advs.202301339

Vancouver

Dong H, Li Q, Zhang Y, Ding M, Teng Z, Mou Y. Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy. Advanced Science. 2023;10(18). doi:10.1002/advs.202301339

BibTeX
@article{Dong2023,
  author = {Dong, Heng and Li, Qiang and Zhang, Yu and Ding, Meng and Teng, Zhaogang and Mou, Yongbin},
  title = {Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {18},
  doi = {10.1002/advs.202301339}
}
Kostenlos starten →